Dummy run study of SABR for recurrence ovarian cancer (SABR-ROC) has been accepted for BMC cancer!

Congratulation! Our paper “Radiotherapy Quality Assurance Program of Ongoing Clinical Trial Using Stereotactic Ablative Radiation Therapy for Recurrent Ovarian Cancer (SABR-ROC): A Dummy Run Study of a Prospective, Randomized, Multicenter Phase III Trial (KGOG 3064/KROG 2204)” has been accepted by BMC cancer (IF=3.4).

I sincerely thank Prof. Yong Bae Kim (PI) for his invaluable support in making this study possible.